References
- UK Department of Health and Social Care, UK Office of National Statistics. London, UK: UK Government; 2021. Accessed 23 June 2022. Available from: https://www.gov.uk/government/publications/dhsc-direct-and-indirect-health-impacts-of-covid-19-in-england-long-paper-9-september-2021
- UK Government. Coronavirus (COVID-19) in the UK: cases in England. London (UK): UK Government; 2022 [ updated 22-Sep-2022; cited 2022 Sept 27]. Available from: https://coronavirus.data.gov.uk/details/cases?areaType=nation&areaName=England
- UK Government. Coronavirus (COVID-19) in the UK: healthcare in England. London (UK): UK Government; 2022 [ updated 22-Sep-2022; cited 2022 Sept 27]. Available from: https://coronavirus.data.gov.uk/details/healthcare?areaType=nation&areaName=England
- UK Government. Coronavirus (COVID-19) in the UK: deaths in England. London (UK): UK Government; 2022 [ updated 22-Sep-2022; cited 2022 Sept 27]. Available from: https://coronavirus.data.gov.uk/details/deaths?areaType=nation&areaName=England
- Hu B, Guo H, Zhou P, et al. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microb. 2021;19(3):141–154.
- UK Government. COVID-19 response: living with COVID-19. London (UK): UK Government; 2022 [ updated May 6, 2022; cited 2022 Jun 23]. Available from: https://www.gov.uk/government/publications/covid-19-response-living-with-covid-19/covid-19-response-living-with-covid-19
- Baraniuk C. Covid-19: how the UK vaccine rollout delivered success, so far. BMJ. 2021;372:n421.
- Ferdinands J, Rao S, Dixon BE, et al. Waning 2-dose and 3-dose effectiveness of mRNA vaccines against COVID-19–associated emergency department and urgent care encounters and hospitalizations among adults during periods of delta and Omicron variant predominance — VISION network, 10 States, August 2021–January 2022. MMWR Morb Mortal Wkly Rep. 2022;71(7):255–263.
- Katikireddi SV, Cerqueira-Silva T, Vasileiou E, et al. Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil. Lancet. 2022;399(10319):25–35.
- Public Health England. Duration of protection of covid-19 vaccines against clinical disease, 9 September 2021. London (UK): UK Government; 2021. Accessed 21 April 2022. Available from https://www.gov.uk/government/publications/phe-duration-of-protection-of-covid-19-vaccines-against-clinical-disease-9-september-2021
- JCVI. JCVI statement regarding a COVID-19 booster vaccine programme for winter 2021 to 2022. London (UK): UK Government; 2021. updated 2021 Sept 14]. Available from https://www.gov.uk/government/publications/jcvi-statement-september-2021-covid-19-booster-vaccine-programme-for-winter-2021-to-2022/jcvi-statement-regarding-a-covid-19-booster-vaccine-programme-for-winter-2021-to-2022
- UK Government. JCVI statement on COVID-19 vaccination of children and young people: 22 December 2021. London (UK): UK Government; 2021. updated 2021 Dec 22. Available from https://www.gov.uk/government/publications/jcvi-update-on-advice-for-covid-19-vaccination-of-children-and-young-people/jcvi-statement-on-covid-19-vaccination-of-children-and-young-people-22-december-2021
- UK Health Security Agency. Weekly national Influenza and COVID-19 surveillance report, Week 12 report (up to week 11 data), cited 2022 Mar 24. London, UK: UK Health Security Agency; 2022. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1062976/Weekly_Flu_and_COVID-19_report_w12.pdf
- Vitiello A, Ferrara F, Auti AM, et al. Advances in the Omicron variant development. J Intern Med. 2022;292(1):81–90.
- Elliott P, Bodinier B, Eales O, et al. Rapid increase in Omicron infections in England during December 2021: REACT-1 study. Science. 2022;375(6587):1406–1411.
- UK Health Security Agency. Technical briefing: update on hospitalisation and vaccine effectiveness for Omicron VOC-21NOV-01 (B.1.1.529). London (UK): UK Health Security Agency; 2021. Accessed 23 June 2022. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1045619/Technical-Briefing-31-Dec-2021-Omicron_severity_update.pdf
- Wolter N, Jassat W, Walaza S, et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet. 2022;399(10323):437–446.
- Mohsin M, Mahmud S. Omicron SARS-CoV-2 variant of concern: a review on its transmissibility, immune evasion, reinfection, and severity. Medicine (Baltimore). 2022;101(19):e29165.
- Nealon J, Cowling BJ. Omicron severity: milder but not mild. Lancet. 2022;399(10323):412–413.
- Bar-On YM, Goldberg Y, Mandel M, et al. Protection by a fourth dose of BNT162b2 against Omicron in Israel. N Engl J Med. 2022;386(18):1712–1720.
- Magen O, Waxman JG, Makov-Assif M, et al. Fourth dose of BNT162b2 mRNA covid-19 vaccine in a nationwide setting. N Engl J Med. 2022;386(17):1603–1614.
- CDC Recommends Additional Boosters for Certain Individuals [Internet]. Centers for Disease Control and Prevention (US); 2022; cited 2022 Mar 29. Available from: https://www.cdc.gov/media/releases/2022/s0328-covid-19-boosters.html
- UK Health Security Agency. COVID-19 vaccine surveillance report, Week 5. London, UK: UK Government; 2022. Accessed 11 August 2022. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1052353/Vaccine_surveillance_report_-_week_5.pdf
- Department of Health and Social Care. Joint Committee on Vaccination and Immunisation (JCVI) statement on COVID-19 vaccinations in 2022: 21 February 2022. London (UK): UK Government; 2022. Accessed 24 June 2022. Available from https://www.gov.uk/government/publications/joint-committee-on-vaccination-and-immunisation-statement-on-covid-19-vaccinations-in-2022/joint-committee-on-vaccination-and-immunisation-jcvi-statement-on-covid-19-vaccinations-in-2022-21-february-2022
- Rough E. Coronavirus: covid-19 booster vaccines frequently asked questions. London (UK): House of Commons Library; 2022. Accessed 18 August 2022. Available from: https://researchbriefings.files.parliament.uk/documents/CBP-9332/CBP-9332.pdf
- UK Government. 2022. Published 15 July, 2022. Accessed 03 August, 2022. Available from:Joint Committee on Vaccination and Immunisation (JCVI) updated statement on the COVID-19 vaccination programme for autumn 2022.https://www.gov.uk/government/publications/jcvi-updated-statement-on-the-covid-19-vaccination-programme-for-autumn-2022/joint-committee-on-vaccination-and-immunisation-jcvi-updated-statement-on-the-covid-19-vaccination-programme-for-autumn-2022
- Andrews N, Stowe J, Kirsebom F, et al. Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England. Nat Med. 2022;28(4):831–837.
- Andrews N, Stowe J, Kirsebom F, et al. Covid-19 vaccine effectiveness against the Omicron (B.1.1.529) variant. N Engl J Med. 2022;386(16):1532–1546.
- Powell AA, Kirsebom F, Stowe J, et al. Effectiveness of BNT162b2 against COVID-19 in adolescents. Lancet Infect Dis. 2022;22(5):581–583.
- UK Health Security Agency. COVID-19 vaccine surveillance report: Week 27. London, UK: UK Government; 2022. Accessed 03 August 2022. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1088974/Vaccine-surveillance-report-week-27.pdf
- Drummond MF. Methods for the economic evaluation of health care programmes. 3 ed. Oxford (UK): Oxford University Press; 2005.
- Bjørnstad ON, Shea K, Krzywinski M, et al. The SEIRS model for infectious disease dynamics. Nat Methods. 2020;17(6):557–558.
- Centre for the Mathematical Modelling of Infectious Diseases (CMMID). COVID-19 working group. CMMID: social contacts in the UK from the CoMix social contact survey London (UK): UK Government; 2020. Accessed 29 April 2022. Available from: https://www.gov.uk/government/publications/cmmid-social-contacts-in-the-uk-from-the-comix-social-contact-survey
- Jarvis C, Gimma, A, Wong K, Edmunds J. Social contacts in the UK from the CoMix social contact survey. Report for survey week 89. 2021. Accessed 13 May 2022. Available from: https://cmmid.github.io/topics/covid19/reports/comix/Comix%20Weekly%20Report%2089.pdf
- UK Health Security Agency Weekly national Influenza and COVID-19 surveillance report; Week 16 report (up to week 15 data); 21 April 2022. Accessed August 03 2022. 2022. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1070353/Weekly_Flu_and_COVID-19_report_w16.pdf
- UK Health Security Agency. COVID-19 vaccine surveillance report, Week 13, 31 March 2022. 2022. Accessed 17 August 2022. London (UK): UK Health Security Agency. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1066759/Vaccine-surveillance-report-week-13.pdf. •• This UK surveillance report is the primary source for inputs related to booster waning rate
- UK Health Security Agency. COVID-19 vaccine surveillance report: week 3. London, UK: UK Government; 2022. Accessed 20 September 2022. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1049160/Vaccine-surveillance-report-week-3-2022.pdf
- UK Health Security Agency. Weekly national Influenza and COVID-19 surveillance report: week 24 report (up to week 23 data); 16 June 2022. Accessed August 03 2022. London, UK: UK Government; 2022. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1083633/Weekly_Flu_and_COVID-19_report_w24_v2.pdf•• This UK surveillance report is the source for rates of booster uptake in the base case.
- NHS. COVID-19-monthly-announced-vaccinations-16-June-2022. Updated 16 June, 2022. Accessed 03 August, 2022. Available from: https://www.england.nhs.uk/statistics/statistical-work-areas/covid-19-vaccinations/covid-19-vaccinations-archive/
- Andrews N, Tessier E, Stowe J, et al. Vaccine effectiveness and duration of protection of Comirnaty, Vaxzevria and Spikevax against mild and severe COVID-19 in the UK.[pre-print]. medRxiv. 2021
- Pouwels KB, Pritchard E, Matthews PC, et al. Impact of Delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK. [pre-print]. medRxiv. 2021
- Andrews N, Stowe J, Kirsebom F, et al. Effectiveness of COVID-19 vaccines against the Omicron (B.1.1.529) variant of concern. [pre-print]. medRxiv. 2021
- UK Health Security Agency. COVID-19 vaccine surveillance report: week 12. London, UK: UK Government; 2022. Accessed 03 August 2022. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1063023/Vaccine-surveillance-report-week-12.pdf•• This UK surveillance report is the primary source for inputs related to booster vaccine effectiveness.
- UK Health Security Agency. COVID-19 vaccine surveillance report, Week 31. London, UK: UK Health Security Agency; 2022. Accessed 10 August 2022. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1096327/Vaccine_surveillance_report_week_31_2022.pdf
- CMMID. Social contacts in the UK from the CoMix social contact survey; Report for survey week 89. London, UK: UK Government; 2021. Accessed 03 August 2022. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1041832/CoMix_Weekly_Report_89.pdf
- CMMID. Social contacts in the UK from the CoMix social contact survey; Report for survey week 92. London, UK: UK Government; 2022. Accessed 03 August 2022. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1046473/S1485_Comix_Report_Survey_Week_92.pdf
- UK Health Security Agency. NHS Test and Trace statistics (England): methodology. London (UK): UK Government; 2022 [updated May 18, 2022; cited 2022 Aug 23]. Available from: https://www.gov.uk/government/publications/nhs-test-and-trace-statistics-england-methodology/nhs-test-and-trace-statistics-england-methodology
- UK Health Security Agency. UKHSA Weekly National Influenza and COVID-19 Report. 7 April 2022 - Week 14 report (up to week 13 data). London, UK: UK Government; 2022. Accessed 12 September 2022. Available from: https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fassets.publishing.service.gov.uk%2Fgovernment%2Fuploads%2Fsystem%2Fuploads%2Fattachment_data%2Ffile%2F1067094%2FWeekly_Influenza_and_COVID19_report_data_w14.ods&wdOrigin=BROWSELINK.
- UK Health Security Agency. SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 34. London (UK): UK Government; 2022. Accessed 21 April 2022. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1050236/technical-briefing-34-14-january-2022.pdf
- UK Health Security Agency. Variants of concern technical briefing 34 (14 January 2022) underlying data. London (UK): UK Government; 2022. Accessed 21 April 2022. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1046608/variants-of-concern-technical-briefing-34-data-england-14-January-2022-1.ods
- UK Health Security Agency. SARS-CoV-2 variants of concern and variants under investigation in England, Technical briefing 40. London (UK): UK Government; 2022. Accessed 11 August 2022. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1067672/Technical-Briefing-40-8April2022.pdf
- Nyberg T, Ferguson NM, Nash SG, et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Lancet. 2022;399(10332):1303–1312.
- Sapey E, Gallier S, Mainey C, et al. Ethnicity and risk of death in patients hospitalised for COVID-19 infection in the UK: an observational cohort study in an urban catchment area. BMJ Open Respir Res. 2020 Sep;7(1):e000644.
- Mason KE, Maudsley G, McHale P, et al. Age-adjusted associations between comorbidity and outcomes of COVID-19: a review of the evidence from the early stages of the pandemic [Review]. Front Public Health. 2021;9:584182.
- Public Health England. National flu and COVID-19 surveillance data report: 8 April 2021 (week 14). London, UK: UK Government; 2021. Accessed 07 December 2022. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/976983/Weekly_Influenza_and_COVID19_report_data_w14.xlsx
- Davies NG, Klepac P, Liu Y, et al. Age-dependent effects in the transmission and control of COVID-19 epidemics. Nat Med. 2020;26(8):1205–1211.
- Sayampanathan AA, Heng CS, Pin, PH, et al. Infectivity of asymptomatic versus symptomatic COVID-19. Lancet. 2021;397(10269):93–94.
- Sandmann FG, Davies NG, Vassall A, et al. The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation. Lancet Infect Dis. 2021;21(7):962–974.
- Hogan AB, Winskill P, Watson OJ, et al. Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: a mathematical modelling analysis. Vaccine. 2021;39(22):2995–3006.
- Jentsch PC, Anand M, Bauch CT. Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study. Lancet Infect Dis. 2021;21(8):1097–1106.
- Moore S, Hill EM, Tildesley MJ, et al. Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study. Lancet Infect Dis. 2021;21(6):793–802.
- Li Y, Ge L, Zhou Y, et al. Toward the impact of non-pharmaceutical interventions and vaccination on the COVID-19 pandemic with time-dependent SEIR model. Front Artif Intell. 2021;4:648579.
- ICNARC. ICNARC report on COVID-19 in critical care: England, Wales and Northern Ireland. cited 2021 Jul 6. London (UK): ICNARC; 2021. Available from: https://www.icnarc.org/DataServices/Attachments/Download/aa75698e-6dde-eb11-9132-00505601089b
- UK Health Security Agency. COVID-19: the green book, chapter 14a. London (UK): UK Government; 2022. Accessed 04 August 2022. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1057798/Greenbook-chapter-14a-28Feb22.pdf
- Hall VJ, Foulkes S, Charlett A, et al. SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN). Lancet. 2021;397(10283):1459–1469.
- Ferguson N, Ghani A, Cori A, et al. Report 49: growth, population distribution and immune escape of Omicron in England. London, UK: Imperial College London; 2021. Accessed 10 August 2022. Available from: https://www.imperial.ac.uk/media/imperial-college/medicine/mrc-gida/2021-12-16-COVID19-Report-49.pdf
- Castanares-Zapatero D, Kohn L, Dauvrin M, et al. Long Covid: Pathophysiology - Epidemiology and Patient Needs: Synthesis. Brussels (Belgium): Belgian Health Care Knowledge Centre (KCE); 2021.
- Vekaria B, Overton C, Wisniowski A, et al. Hospital length of stay for COVID-19 patients: data-driven methods for forward planning. BMC Infect Dis. 2021 Jul 22;21(1):700.
- Jones R, Craig H COVID Test and Trace Cases Insights Survey. cited 2022 Jan 4 to 8. London (UK): UK Government; 2022. Available from: https://www.ons.gov.uk/file?uri=/peoplepopulationandcommunity/healthandsocialcare/healthandwellbeing/datasets/coronavirusandselfisolationaftertestingpositiveinengland/4to8january2022/datatablestestandtracecasesinsightssurvey4jan8jan2022.xlsx
- Office for National Statistics (UK). A05 SA: employment, unemployment and economic inactivity by age group (seasonally adjusted). London (UK): UK Government; 2022. Accessed 24 May 2022. Available from: https://www.ons.gov.uk/employmentandlabourmarket/peopleinwork/employmentandemployeetypes/datasets/employmentunemploymentandeconomicinactivitybyagegroupseasonallyadjusteda05sa
- Office for National Statistics (UK). Leisure time in the UK: 2015. London (UK): UK Government; 2017. Accessed 13 May 2022. Available from: https://www.ons.gov.uk/economy/nationalaccounts/satelliteaccounts/articles/leisuretimeintheuk/2015/pdf
- Mendes D, Chapman R, Gal P, et al. Public health impact of booster vaccination against COVID-19 in the UK during Delta variant dominance in autumn 2021. J Med Econ. 2022;25(1):1039–1050.
- Almost 80% of eligible over-75s receive spring booster [Internet]. 2022. Accessed 12 August 2022. Available from: https://www.gov.uk/government/news/almost-80-of-eligible-over-75s-receive-spring-booster
- UK Health Security Agency. UKHSA Weekly National Influenza and COVID-19 Report, cited 2022 Mar 31. London, UK: UK Government; 2022.
- UK Health Security Agency. Seasonal flu vaccine uptake in children of school age: provisional monthly data for 1 September 2021 to 31 January 2022. London (UK): UK Government; 2022. Accessed 12 August 2022. Available from https://www.gov.uk/government/statistics/seasonal-flu-vaccine-uptake-in-children-of-school-age-monthly-data-2021-to-2022
- Walker JL, Grint DJ, Strongman H, et al. UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health records. BMC Public Health. 2021;21(484). DOI:10.1186/s12889-021-10427-2.
- Barnard RC, Davies NG, Munday JD, et al., Modelling the medium-term dynamics of SARS-CoV-2 transmission in England in the Omicron era. Nat Commun. 2022;13(1):4879.
- Keeling MJ, Moore SE. An assessment of the vaccination of school-aged children in England against SARS-CoV-2. BMC Med. 2022;20(1):196.
- Gavish N, Yaari R, Huppert A, et al. Population-level implications of the Israeli booster campaign to curtail COVID-19 resurgence. Sci Transl Med. 2022;14(647):eabn9836.
- Brown K, Pappachan JV, McKee M. What should be done to protect children from COVID-19 in the UK? Arch Dis Child. 2022;archdischild-2022–323839. DOI:10.1136/archdischild-2022-323839
- Merchant HA. Why COVID vaccines for young children (5–11 years) are not essential at this moment in time? J Pharm Policy Pract. 2022;15(1):25.
- Ward JL, Harwood R, Smith C, et al. Risk factors for PICU admission and death among children and young people hospitalized with COVID-19 and PIMS-TS in England during the first pandemic year. Nat Med. 2022;28(1):193–200.
- Smith C, Odd D, Harwood R, et al. Deaths in children and young people in England after SARS-CoV-2 infection during the first pandemic year. Nat Med. 2022;28(1):185–192.
- Lyngse FP, Mortensen LH, Denwood MJ, et al. SARS-CoV-2 Omicron VOC transmission in Danish Households. .[pre-print]. medRxiv. 2021.
- Regev-Yochay G, Gonen T, Gilboa M, et al. 4th dose COVID mRNA vaccines’ immunogenicity & efficacy against Omicron VOC. medRxiv. 2022
- JCVI. Joint Committee on Vaccination and Immunisation: advice on priority groups for COVID-19 vaccination, cited 2020 Dec 30. London (UK): UK Government; 2021. Available from: https://www.gov.uk/government/publications/priority-groups-for-coronavirus-covid-19-vaccination-advice-from-the-jcvi-30-december-2020/joint-committee-on-vaccination-and-immunisation-advice-on-priority-groups-for-covid-19-vaccination-30-december-2020#:~:text=JCVI%20advises%20that%20the%20first,is%20primarily%20based%20on%20age
- Medicines & Healthcare products Regulatory Agency. Coronavirus vaccine - summary of Yellow Card reporting London, UK: UK Government; 2022 [ updated August 4, 2022; accessed 2022 Aug 24]. Available from: https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting#yellow-card-reports
- Townsend JP, Lamb AD, Hassler HB, et al. Projecting the seasonality of endemic COVID-19. [pre-print]. medRxiv. 2022